Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001253290 | SCV001428936 | uncertain significance | Glaucoma 3A | 2017-08-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568730 | SCV003554450 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.908A>C (p.K303T) alteration is located in exon 2 (coding exon 1) of the CYP1B1 gene. This alteration results from a A to C substitution at nucleotide position 908, causing the lysine (K) at amino acid position 303 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004692352 | SCV005187619 | uncertain significance | not provided | criteria provided, single submitter | not provided |